When WW launched a new compounded semaglutide product late last year, the stock surged, renewing hopes of growth revival.

Hims & Hers Health shows impressive operating leverage and a scalable business model, with massive growth potential from new ...

Today, companies across sectors including Tata Steel, Ather Energy, Bajaj Electricals, PVR INOX, Raymond, Siyaram Silk Mills, ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in ...

After 12 weeks, weight loss with the drug was 13% of body weight, compared to 1% with placebo, which the company said was around twice the level achieved with Wegovy (semaglutide) at that time point.

Common Sense is dedicated to improving the lives of kids and families by providing the trustworthy information, education, and independent voice they need to thrive.